Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 23, 2015 3:18 AM ET

Healthcare Providers and Services

Company Overview of Good Start Genetics, Inc.

Company Overview

Good Start Genetics, Inc., a molecular diagnostics company, provides genetic screening of inherited diseases. The company was founded in 2007 and is based in Cambridge, Massachusetts.

237 Putnam Avenue

Cambridge, MA 02139

United States

Founded in 2007

Phone:

617-714-0800

Fax:

617-714-0801

Key Executives for Good Start Genetics, Inc.

Chief Executive Officer, President and Director
Age: 63
Co-Founder and Vice President of Business Development
Co-Founder and Vice President of Research & Technology
Chief Financial Officer
Chief Information Officer
Compensation as of Fiscal Year 2014.

Good Start Genetics, Inc. Key Developments

Good Start Genetics, Inc. Appoints Charles F. Wagner, Jr. to the Company's Board of Directors

Good Start Genetics, Inc. announced the appointment of Charles F. Wagner, Jr. to the company's board of directors. Mr. Wagner is currently chief financial officer and executive vice president, finance and administration of Bruker Corporation. Prior to Bruker, Mr. Wagner served as chief financial officer and executive vice president, finance and administration of Progress Software Corporation. Earlier, Mr. Wagner served as chief financial officer and vice president of Millipore Corporation.

Good Start Genetics Announces the Data from Validation Study and Clinical Data Demonstrating Accuracy of Their NGS-Based Carrier Screening Test

Good Start Genetics, Inc. announced the data from validation studies plus data from more than 11,000 patient samples tested in its clinical laboratory. The findings demonstrate that nearly 25% of the distinct pathogenic mutations and more than 5% of carriers detected by Good Start Genetics would have been missed by other commercially available genotyping screens utilizing traditional technologies. By arming physicians and patients with this actionable information, GoodStart Select(TM), the menu of carrier screening tests offered by Good Start Genetics, therefore has the potential to provide couples with greater certainty concerning their risk of conceiving a child with a debilitating or fatal inherited disease. The study, conducted by Good Start Genetics' team of clinical geneticists and scientists, evaluated 11,691 patients from in vitro fertilization (IVF) centers across the United States which used GoodStart Select screening tests, and identified 449 pathogenic mutations among 15 genes that are associated with 14 fatal or debilitating genetic diseases. Eighty-seven of these mutations were classified as distinct, and about one quarter of those would be missed by other commercially available genetic screening tests utilizing traditional, limited mutation panels, including 16 known mutations unique to GoodStart Select, and seven previously unreported mutations detected by this technology. More than 5% of patients that are carriers would have been missed if these traditional screening methods were used. By providing physicians and patients with additional actionable information, GoodStart Select has the potential to provide reproductive couples with greater certainty concerning their risk of conceiving a child with a debilitating or fatal genetic disorder.

Good Start Genetics, Inc. Announces Contract with Tufts Health Plan to Cover GoodStart Select Carrier Screening Test

Good Start Genetics, Inc. announced that the company has signed a coverage agreement with Tufts Health Plan for its GoodStart Select carrier screening test. The information provided through carrier screening is often used to help guide reproductive decisions, so it is important that the information physicians and prospective parents receive from these tests is not only accurate, but comprehensive as well. The agreement covers the full menu of carrier screening tests developed by Good Start Genetics to screen for all 23 disorders recommended by leading medical societies.

Similar Private Companies By Industry

Company Name Region
IOM Health System LP United States
Hemophilia Of Georgia, Inc. United States
Renown Health United States
PocketDerm, Inc. United States
Poplar Bluff Regional Medical Center, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Good Start Genetics, Inc., please visit www.goodstartgenetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.